MPR Weekly Dose #58 - Major developments in COVID vaccine and antibody treatments; Also an FDA Advisory Committee vote on what would be the first Alzheimer drug in decades.

Major developments in COVID-19 vaccine and antibody treatments: Are we close to having a vaccine gain Emergency Use Authorization? The antibody bamlanivimab is given Emergency Use Authorization; An NIH study concluded that hydroxychloroquine has no clinical benefit; And unrelated to COVID, but still big news, the Advisory Committee have voted on what would-be the first Alzheimer disease treatment in decades.